RT Journal Article
SR Electronic
T1 Ensemble model estimates of the global burden of measles morbidity and mortality from 2000 to 2019: a modeling study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.31.21262916
DO 10.1101/2021.08.31.21262916
A1 Heather Santos
A1 Kirsten Eilertson
A1 Brian Lambert
A1 Sarah Hauryski
A1 Minal Patel
A1 Matthew Ferrari
YR 2021
UL http://medrxiv.org/content/early/2021/10/26/2021.08.31.21262916.abstract
AB Background Measles remains a significant source of childhood morbidity and mortality worldwide. Two doses of measles containing vaccine are recommended for all children and delivered through a combination of routine and supplemental immunization activities. Uncertainty about the degree to which second dose opportunities reach previously unvaccinated children presents a challenge in the assessment of vaccination programs and the estimation of the global burden of measles disease and mortality.Methods We fit an ensemble of models that represent alternative assumptions about the degree to which second dose opportunities reach previously unvaccinated children to routine measles surveillance from 100 countries. Using maximum likelihood we selected the best fit model for each country. We compare the resulting estimates of the burden of measles disease and mortality to existing methods for estimating the burden of measles that assume that second dose opportunities are independent of receipt of the first dose.Findings We find that 55 of 100 countries are best-fit by a model that assumes that second dose opportunities that are delivered through routine vaccination or supplemental campaigns are preferentially delivered to children who have received a first dose. Using a country-specific best-fit model we estimate that measles mortality has declined by 71% from 2000-2019 compared to an estimated decline of 83% using an assumption of independent doses in all countries.Interpretation Despite large decreases in measles cases over the last two decades, the observed trajectories in most countries suggest that supplemental immunization activities are disproportionately reaching previously vaccinated children. To accelerate measles reduction goals efforts to reach unvaccinated children through supplemental activities and second dose opportunities should be intensified.Funding Bill and Melinda Gates Foundation, World Health OrganizationCompeting Interest StatementMF has received funding from the Bill and Melinda Gates Foundation, the US Centers for Disease Control and Prevention, and the World Health Organization. MF and KE have received funding from Gavi, the vaccine alliance. MP was a CDC detailee to WHO from 2016-2021.Funding StatementMF, SH, HS, BL, KE were supported by a grant from Gavi, the vaccine alliance. MF was supported by a grant from the Bill and Melinda Gates Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our work with the anonymized and aggregated data provided by WHO and used in the study does not quality as human subjects research as defined by the university IRB.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to this manuscript are available at the websites referenced in the text. https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencemeasles.html https://population.un.org/wpp/ https://cdn.who.int/media/docs/default-source/immunization/data_statistics/summary_measles_sias.xls?sfvrsn=77c794e8_6